001     178524
005     20240229143549.0
024 7 _ |a 10.1053/j.gastro.2022.01.011
|2 doi
024 7 _ |a pmid:35031300
|2 pmid
024 7 _ |a 0016-5085
|2 ISSN
024 7 _ |a 1528-0012
|2 ISSN
024 7 _ |a altmetric:120969708
|2 altmetric
037 _ _ |a DKFZ-2022-00121
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lam, Suk Yee
|b 0
245 _ _ |a Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers.
260 _ _ |a Philadelphia, Pa. [u.a.]
|c 2022
|b Saunders
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1651150741_30566
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 May;162(6):1705-1715
520 _ _ |a A genome-wide significant association between anti-Helicobacter pylori (H. pylori) IgG titers and Toll-like receptor (TLR1/6/10) locus on 4p14 was demonstrated for individuals of European ancestry, but not uniformly replicated. We re-investigate this association in an updated genome-wide association study (GWAS) meta-analysis for low gastric cancer incidence populations, address potential causes of cohort heterogeneity and explore functional implications of genetic variation at the TLR1/6/10 locus.The dichotomous GWAS (25% individuals exhibiting highest anti-H. pylori IgG titers versus remaining 75%) included a discovery and replication sample of respectively n=15,685 and n=9,676, all of European ancestry. Longitudinal analysis of serological data was performed on H. pylori-eradicated subjects (n=132) and patients under surveillance for premalignant gastric lesions (n=107). TLR1/6/10 surface expression, TLR1 messenger RNA (mRNA) and cytokine levels were measured in leukocyte subsets of healthy subjects (n=26) genotyped for TLR1/6/10 variants.The association of the TLR1/6/10 locus with anti-H. pylori IgG titers (rs12233670; β=-0.267 SE±0.034; P=4.42x10-15) presented with high heterogeneity and failed replication. Anti-H. pylori IgG titers declined within 2-4 years following eradication treatment (P=0.004), and decreased over time in patients with premalignant gastric lesions (P<0.001). Variation at the TLR1/6/10 locus affected TLR1-mediated cytokine production and TLR1-surface expression on monocytes (P=0.016) and neutrophils (P=0.030), but not mRNA levels.The association between anti-H. pylori IgG titers and TLR1/6/10 locus was not replicated across cohorts, possibly due to dependency of anti-H. pylori IgG titers on therapy, clearance and antibody decay. H. pylori-mediated immune cell activation is partly mediated via TLR1 signaling, which in turn is affected by genetic variation.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Polymorphism
|2 Other
650 _ 7 |a Single Nucleotide
|2 Other
650 _ 7 |a bacteria
|2 Other
650 _ 7 |a immunity
|2 Other
650 _ 7 |a serology
|2 Other
700 1 _ |a Mommersteeg, Michiel C
|b 1
700 1 _ |a Yu, Bingting
|b 2
700 1 _ |a Broer, Linda
|b 3
700 1 _ |a Spaander, Manon C W
|b 4
700 1 _ |a Frost, Fabian
|b 5
700 1 _ |a Weiss, Stefan
|b 6
700 1 _ |a Völzke, Henry
|b 7
700 1 _ |a Lerch, Markus M
|b 8
700 1 _ |a Schöttker, Ben
|0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
|b 9
|u dkfz
700 1 _ |a Zhang, Yan
|0 P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d
|b 10
700 1 _ |a Stocker, Hannah
|0 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
|b 11
|u dkfz
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 12
|u dkfz
700 1 _ |a Levy, Daniel
|b 13
700 1 _ |a Hwang, Shih-Jen
|b 14
700 1 _ |a Wood, Alexis C
|b 15
700 1 _ |a Rich, Stephen S
|b 16
700 1 _ |a Rotter, Jerome I
|b 17
700 1 _ |a Taylor, Kent D
|b 18
700 1 _ |a Tracy, Russell P
|b 19
700 1 _ |a Kabagambe, Edmond K
|b 20
700 1 _ |a Leja, Marcis
|b 21
700 1 _ |a Klovins, Janis
|b 22
700 1 _ |a Peculis, Raitis
|b 23
700 1 _ |a Rudzite, Dace
|b 24
700 1 _ |a Nikitina-Zake, Liene
|b 25
700 1 _ |a Skenders, Girts
|b 26
700 1 _ |a Rovite, Vita
|b 27
700 1 _ |a Uitterlinden, André
|b 28
700 1 _ |a Kuipers, Ernst J
|b 29
700 1 _ |a Fuhler, Gwenny M
|b 30
700 1 _ |a Homuth, Georg
|b 31
700 1 _ |a Peppelenbosch, Maikel P
|b 32
773 _ _ |a 10.1053/j.gastro.2022.01.011
|g p. S0016508522000191
|0 PERI:(DE-600)1478699-0
|n 6
|p 1705-1715
|t Gastroenterology
|v 162
|y 2022
|x 0016-5085
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178524
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GASTROENTEROLOGY : 2021
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b GASTROENTEROLOGY : 2021
|d 2022-11-17
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21